Sudo and Schnell Korea reported business losses.

During the shareholder's meeting of the pharmaceutical companies for the fiscal year ended in Sept. 30 (Oct. 1, 2002 to Sept. 30, 2003), Sudo pharmaceutical company reported 16,160 million won of sales and losses in ordinary and net profits at their 37th shareholder's meeting on Dec. 24.

Shin Dongbang Medics merged Kuhnpoong and changed the company name as Schnell Korea on Dec. 2002. In the...